Sean Salmon - Aug 2, 2024 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Aug 2, 2024
Transactions value $
-$280,068
Form type
4
Date filed
8/6/2024, 06:14 PM
Previous filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $0 +5.46K +8.66% $0.00 68.5K Aug 2, 2024 Direct F1
transaction MDT Ordinary Shares Tax liability -$53.6K -657 -0.96% $81.51 67.9K Aug 2, 2024 Direct F2
transaction MDT Ordinary Shares Tax liability -$227K -2.78K -4.09% $81.51 65.1K Aug 2, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Options Exercise $0 -5.46K -100% $0.00* 0 Aug 2, 2024 Performance Share Units 5.46K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 4,369 shares will be delivered to the reporting person when his employment with the Company ends.
F2 Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
F3 Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
F4 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5 The performance share units vested on August 2, 2024.